Frequently Asked Questions
The market is segmented based on , By Product Type (Transplant Diagnostic Instrument, Transplant Diagnostic Software, Transplant Diagnostic Reagent), Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays), Transplant Type (Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation, Other), Application (Diagnostic Applications, Research Applications), End User (Research Laboratories and Academic Institutes, Hospital and Transplant Centers, Commercial Service Providers, Others), Distribution Channel (Direct Tender, Retail Sales and Others) – Industry Trends and Forecast to 2031.
.
The Global Transplant Diagnostics Market size was valued at USD 6.83 USD Billion in 2024.
The Global Transplant Diagnostics Market is projected to grow at a CAGR of 6.8% during the forecast period of 2025 to 2031.
The major players operating in the market include , Hologic , Biofortuna Limited , Takara Bio , Abbott , Diagnóstica Longwood SL , Adaptive Biotechnologies , NanoString Technologies , Arquer Diagnostics Ltd , altona Diagnostics GmbH , ELITechGroup , DiaSorin S.p.A. , Horiba Ltd , Eurofins Viracor , CareDx , Laboratory Corporation of America Holdings , Randox Laboratories , Thermo Fisher Scientific ,.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and the rest of Europe, China, Japan, India, South Korea, Singapore, Thailand, Malaysia, Australia, Philippines, Indonesia and the rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E, Egypt, Israel and the rest of the Middle East and Africa.
